Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia.
about
Spread of artemisinin resistance in Plasmodium falciparum malariaA molecular marker of artemisinin-resistant Plasmodium falciparum malariaArtemisinin-based antimalarial research: application of biotechnology to the production of artemisinin, its mode of action, and the mechanism of resistance of Plasmodium parasitesAntimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR NetworkPlasmodium falciparum susceptibility to antimalarial drugs: global data issued from the Pasteur Institutes international networkThe interplay between drug resistance and fitness in malaria parasitesSynthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine PhosphoribosyltransferasesPolymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan ChildrenGenome-wide association analysis identifies genetic loci associated with resistance to multiple antimalarials in Plasmodium falciparum from China-Myanmar borderExported Epoxide Hydrolases Modulate Erythrocyte Vasoactive Lipids during Plasmodium falciparum InfectionPlasmodium falciparum: multifaceted resistance to artemisininsArtemisinin Action and Resistance in Plasmodium falciparumTargeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistancePlasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasitesA tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance.Laboratory detection of artemisinin-resistant Plasmodium falciparumEx vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.Altered temporal response of malaria parasites determines differential sensitivity to artemisininRole of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisininDelayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central VietnamLimited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013Antimalarial action of artesunate involves DNA damage mediated by reactive oxygen speciesReduced polymorphism in the Kelch propeller domain in Plasmodium vivax isolates from Cambodia.In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season.Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humansIdentification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strainsSpread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker.Artemisinin-resistant Plasmodium falciparum parasites exhibit altered patterns of development in infected erythrocytesImpact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.Observing in real time the evolution of artemisinin resistance in Plasmodium falciparumUse of Plasmodium falciparum culture-adapted field isolates for in vitro exflagellation-blocking assayComparison between Flow Cytometry, Microscopy, and Lactate Dehydrogenase-Based Enzyme-Linked Immunosorbent Assay for Plasmodium falciparum Drug Susceptibility Testing under Field ConditionsPrevalence of K13-propeller gene polymorphisms among Plasmodium falciparum parasites isolated from adult symptomatic patients in northern Uganda.Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure.Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria.
P2860
Q21032481-C3A51B7D-3771-470A-9BA7-EC418F487346Q22061872-8DD1538D-622C-4B22-9C48-2F52720EF906Q26744159-FD8E48F1-1764-4F17-986E-7826E63E9E83Q26799713-EAB021C4-B1E3-4068-B69A-D3B86182BEC5Q26860875-4B85B4A5-04F1-4E76-A61C-6DF447A8623FQ26998596-13EBD7DF-B41C-4375-8295-7C2E7559EC7EQ27702146-FB6B668C-EF26-4D27-8FCC-F63FDB0B38B1Q27861962-52F8C78A-B402-485B-BB73-0435507F841BQ27973054-62C95CBE-BF1C-4A9D-80EF-A2B95F6661D4Q27974556-314D37DB-DF87-496A-92DF-0129F5B632DDQ28069384-D45FB17F-9535-4544-801F-03E0CE186467Q28276294-1D6973E7-04E3-43A0-9438-CF1764BEEEBEQ28546636-52AF808B-EBE6-4DF2-BE11-587075292702Q30240158-6D9B62C2-0D5D-435B-99C5-010F39C29225Q30379780-4524FEDA-B506-4C61-9D7F-CFDB086E17E3Q30619647-3A90567F-DB1F-437D-817A-EBCBA568FDA3Q33655603-A37B21AC-5A6B-4DA9-A9CF-5F381971CF3EQ33725824-82F0DC5C-C5C3-4553-9DFA-13D021D61C12Q33761137-61561735-A4DC-4527-B9C4-70E9B9E4E266Q33798139-F42828D5-A3B4-446E-81CE-47F7724D9396Q34298916-80597020-D7DD-472B-8CA0-B36875BE6D53Q34329125-5B7C0C3A-7EFB-4386-B5B7-F4501F1E98F8Q34597550-EC75F116-DC80-4172-BF81-F7670BE8576DQ34597617-04CD1E51-6A15-47A2-8E38-6D3699BCA7CEQ34891749-923659D9-F279-4BBB-A954-16599D2BCFD1Q34922467-E27E8F33-B84B-49DF-A919-3708476F3DE0Q34923492-684AF809-7249-4CCD-BC03-CBFB8A01D4B7Q35099599-4315AE61-9968-467B-9FB0-E5DB4100F6AAQ35101288-C7F3556B-5F17-49C6-82D6-74372B91FD54Q35105899-DB27F134-D4C5-4B28-83D2-C34C40656786Q35106020-4CBD016F-40D9-4C1D-B7A6-641A99FED5CCQ35217991-70B0A278-F4D4-484D-84A8-EACE04043690Q35607727-B83DCB39-E0B3-4B89-A526-9C41E90EC7B4Q35607844-011EE9C9-E462-49E4-A2CD-3BC61043C457Q35608785-046FC73E-8BB9-4F13-A2A3-F24FC804AB9BQ35730764-B8205CF6-960D-4D6B-8B76-01C03A6F1CC1Q36066881-37BA65A1-B4D5-455B-B143-535CDB3E99B1Q36108352-0B8361AF-18FE-45F2-9166-239F6019F036Q36121601-DF84B396-199B-441A-AB95-D8E6E670EB24Q36125476-4649053E-41D2-43D6-8AE1-661773E96F4E
P2860
Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Reduced artemisinin susceptibi ...... ng stages in western Cambodia.
@ast
Reduced artemisinin susceptibi ...... ng stages in western Cambodia.
@en
type
label
Reduced artemisinin susceptibi ...... ng stages in western Cambodia.
@ast
Reduced artemisinin susceptibi ...... ng stages in western Cambodia.
@en
prefLabel
Reduced artemisinin susceptibi ...... ng stages in western Cambodia.
@ast
Reduced artemisinin susceptibi ...... ng stages in western Cambodia.
@en
P2093
P2860
P50
P921
P356
P1476
Reduced artemisinin susceptibi ...... ng stages in western Cambodia.
@en
P2093
Antoine Berry
Benoit Witkowski
Françoise Benoit-Vical
Jean-Christophe Barale
Nimol Khim
Nimol Kloeung
Olivier Gorgette
Pascal Ringwald
Pheaktra Chim
Rithea Leang
P2860
P304
P356
10.1128/AAC.01868-12
P407
P577
2012-12-03T00:00:00Z